IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE

IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE

Aim. To estimate the role of immuno-inflammatory response in developing of angina pectoris in patients with ischemic heart disease (IHD).Material and methods: The study included 83 patients with IHD and angina pectoris of functional class (FC) II (30 patients), III (27 patients) and IV (26 patients)...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. E. Zakirova, N. Kh. Khafizova, I. M. Karamova, A. N. Zakirova, R. G. Oganov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	ischemic heart disease angina pectoris immuno-inflammatory response cytokines
Online Access:	https://www.rpcardio.online/jour/article/view/405
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IMMUNO-INFLAMATORY RESPONSES IN ACUTE CORONARY SYNDROME
by: R. G. Oganov, et al.
Published: (2015-12-01)

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE
by: A. N. Zakirova, et al.
Published: (2015-12-01)

ENDOTHELIAL DYSFUNCTION IN ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2016-01-01)

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016-01-01)

TREATMENT ADHERENCE AND QUALITY OF LIFE OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE IN TREATMENT WITH NICORANDIL: INTERRELATION AND INTERACTION (ACCORDING TO THE RESULTS OF THE OBSERVATIONAL STUDY NIKEA)
by: S. Yu. Martsevich, et al.
Published: (2018-07-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Probucol and ciprofibrate effects on lipid peroxidation, blood rheology, and angina pectoris clinical course
by: A. N. Zakirova, et al.
Published: (2005-02-01)

Relationship between systemic inflammatory response and hypercoagulation in patients with immuno-inflammatory rheumatic diseases
by: Yu. A. Zhuravleva, et al.
Published: (2023-06-01)

CORONARY HEART DISEASE IN PERSONS OLDER THAN 55 YEARS. PREVALENCE AND PROGNOSIS
by: S. A. Shalnova, et al.
Published: (2014-08-01)

IMMUNO-CORRECTING THERAPY AND INCREASED NITRATE EFFECTIVENESS IN ANGINA TREATMENT
by: V. V. Anikin, et al.
Published: (2010-10-01)

THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-09-01)

Janus kinase inhibitors in immuno-inflammatory rheumatic diseases: new opportunities and prospects
by: E. L. Nasonov, et al.
Published: (2019-03-01)

THE DYNAMICS OF LIFE QUALITY PARAMETERS WITH NICORANDIL USAGE IN STABLE CORONARY HEART DISEASE PATIENTS (RESULTS OF THE OBSERVATION STUDY “NIKEA”)
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)

Comparative analysis of adherence to treatment in patients with various forms of coronary heart disease
by: A. I. Pavlov, et al.
Published: (2023-04-01)

PERCUTANEOUS INTERVENTION IN STABLE ANGINA: WHAT ISSUES DO WE SOLVE?
by: Yu. A. Karpov, et al.
Published: (2018-04-01)

ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION
by: A. N. Zakirova, et al.
Published: (2015-09-01)

Spinal cord stimulation in the treatment of refractory angina pectoris: 25-year clinical experience at a single center
by: Jan Naar, et al.
Published: (2025-06-01)

LEVELS OF INTERLEUKINS AND MELATONIN IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: M. A. Shalenkova, et al.
Published: (2014-11-01)

THE ERYTHROCYTE MEMBRANE ENDURANCE AGAINST TISSUE ISCHEMIA IN PATIENTS WITH HYPERTENSIVE DISEASE AND ISCHEMIC HEART DISEASE AND ITS RELATIONSHIP WITH ENDOGENOUS FACTORS
by: A. S. Sergeeva, et al.
Published: (2014-11-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

FIVE YEAR PROGNOSIS IN PATIENTS WITH CORONARY HEART DISEASE AND COMORBIDITIES: DATA FROM MULTICENTER STUDY IN INGUSHETIA REPUBLIC
by: P. O. Ugurchieva, et al.
Published: (2018-04-01)

RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Pharmacological treatment of stable angina pectoris: the place of trimetazidine
by: E. A. Temnikova
Published: (2022-12-01)

ASSESSMENT OF ADHERENCE TO TREATMENT AND FACTORS AFFECTING IT IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DURING THERAPY WITH NICORANDIL
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)

Adherence to therapy, lifestyle modification and medical support of cardiovascular patients
by: S. S. Bunova, et al.
Published: (2020-12-01)

Levels of serum IL-1β, IL-2, IL-8 and tumor necrosis factor-α in patients with unstable angina pectoris
by: Ali Ozeren, et al.
Published: (2003-01-01)

EFFECT OF FERROTHERAPY ON COURSE OF ISCHEMIC HEART DISEASE ASSOCIATED WITH MILD IRON DEFICIENCY IN MEN
by: N. S. Belousova, et al.
Published: (2016-01-01)

Does Green Brazilian Propolis Extract Improve Functional Capacity in Symptomatic Chronic Coronary Disease?—A Pilot Randomized Trial
by: Clara Salles Figueiredo, et al.
Published: (2025-05-01)

Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study
by: Luís Henrique Wolff Gowdak, et al.
Published: (2025-04-01)

Factors Associated with Congestive Heart Failure among Patients Presenting with Acute Cardiac Emergencies in Northern Lahore
by: Kamran Baber, et al.
Published: (2024-01-01)

EFFICACY AND SAFETY OF IVABRADINE AND BISOPROLOL IN PATIENTS WITH ISCHEMIC HEART DISEASE: RESULTS OF COMPARATIVE RANDOMIZED OPEN STUDY
by: R. D. Kurbanov, et al.
Published: (2016-01-01)

Evaluating the impact of metabolic indicators and scores on cardiovascular events using machine learning
by: Guanmou Li, et al.
Published: (2025-05-01)

The efficacy and safety of coronary sinus reducer in refractory angina: a systematic review and meta-analysis
by: Ahmed Elshahat, et al.
Published: (2025-07-01)

SPECIFIC PROPERTIES OF THE DRUG THERAPY FOR STABLE ANGINA IN MEN
by: R. G. Oganov, et al.
Published: (2014-04-01)

Probiotic Bifidobacterium reduces serum TMAO in unstable angina patients via the gut to liver to heart axis
by: Zhihong Zhou, et al.
Published: (2025-03-01)

Sex differences in health status trajectories among Chinese angina patients: a post-hoc analysis of the GREAT multicenter prospective cohort
by: Yanfang Wu, et al.
Published: (2025-07-01)

THE INFLUENCE OF VHF ELECTROMAGNETIC RADIATION ON THE FREQUENCIES OF MOLECULAR SPECTRUM AND OXYGEN ABSORPTION ON BLOOD REOLOGICAL PROPERTIES IN STABLE ANGINA
by: V. F. Kirichuk, et al.
Published: (2002-02-01)

Influence of basic complex two-year therapy on indicators of late remodeling of the left ventricle and prophylaxis of the occurrence of cardiovascular events in patients after unstable angina combined with arterial hypertension
by: O. V. Denesiuk, et al.
Published: (2019-09-01)

Nursing diagnosis of physical order in women with angina pectoris
by: Marcos Venícios de Oliveira Lopes, et al.
Published: (2000-02-01)

The relationship between hypertension and angina pectoris; physiological & Biochemical study of patients Samarra city
by: Mostafa A. Abdulrahman
Published: (2023-02-01)